Aethlon Medical (AEMD) Free Cash Flow Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Aethlon Medical | 1.14 Mn | -5.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23.24% |
| Sep 30, 2025 | 27.31% |
| Jun 30, 2025 | -8.90% |
| Mar 31, 2025 | -0.57% |
| Dec 31, 2024 | 28.94% |
| Sep 30, 2024 | 30.99% |
| Jun 30, 2024 | -6.96% |
| Mar 31, 2024 | -12.96% |
| Dec 31, 2023 | -17.05% |
| Sep 30, 2023 | -22.29% |
| Jun 30, 2023 | -27.08% |
| Mar 31, 2023 | -23.75% |
| Dec 31, 2022 | -21.64% |
| Sep 30, 2022 | -28.60% |
| Jun 30, 2022 | -20.33% |
| Mar 31, 2022 | -27.90% |
| Dec 31, 2021 | -28.63% |
| Sep 30, 2021 | -15.41% |
| Jun 30, 2021 | -20.53% |
| Mar 31, 2021 | -14.76% |
| Dec 31, 2020 | -18.03% |
| Sep 30, 2020 | 3.07% |
| Jun 30, 2020 | -7.01% |
| Mar 31, 2020 | 3.07% |
| Dec 31, 2019 | 6.08% |
| Sep 30, 2019 | -13.59% |
| Jun 30, 2019 | -10.33% |
| Mar 31, 2019 | -18.84% |
| Dec 31, 2018 | -3.81% |
| Sep 30, 2018 | -13.65% |
| Jun 30, 2018 | -29.86% |
| Mar 31, 2018 | -14.34% |
| Dec 31, 2017 | -3.60% |
| Sep 30, 2017 | -11.56% |
| Jun 30, 2017 | -27.95% |
| Mar 31, 2017 | -5.50% |
| Dec 31, 2016 | -64.70% |
| Sep 30, 2016 | -13.59% |
| Jun 30, 2016 | -8.87% |
| Mar 31, 2016 | -19.87% |
| Dec 31, 2015 | -12.03% |
| Sep 30, 2015 | -19.09% |
| Jun 30, 2015 | -17.07% |